Acharya Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.20 M
- Revenue Growth -1.57%
- Profit Growth -413.85%
- Ebitda -30.71%
- Net Worth -17.62%
- Total Assets 4.06%
About Acharya Pharmacy
Acharya Pharmacy Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 December 2014 and has a history of Ten years and one month. Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.20 M.
Biranchi Dash and Sarojini Dash serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397OR2014PTC018526
-
Company No.
018526
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Dec 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Acharya Pharmacy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarojini Dash
|
Managing Director | 18-Dec-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Biranchi Dash
|
Director | 18-Dec-2014 | Current |
Financial Performance of Acharya Pharmacy.
Acharya Pharmacy Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 1.57% decrease. The company also saw a substantial fall in profitability, with a 413.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acharya Pharmacy?
In 2021, Acharya Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Basasthanam Developers Private LimitedBiranchi Dash and Sarojini Dash are mutual person
Charges (Loans)
₹2.20 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2016 | Others | ₹2.20 M | Open |
How Many Employees Work at Acharya Pharmacy?
Unlock and access historical data on people associated with Acharya Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acharya Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acharya Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.